Journal
TRENDS IN CARDIOVASCULAR MEDICINE
Volume 26, Issue 8, Pages 663-672Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2016.05.001
Keywords
Cardiomyopathy; Genetic; Induced pluripotent stem cell; Inherited
Categories
Funding
- National Health and Medical Research Council, Australia (NHMRC) [1059156]
- Australian Postgraduate Award
Ask authors/readers for more resources
Inherited cardiomyopathies lead to diverse clinical outcomes including heart failure, arrhythmias, and sudden death. Mutations in over 100 genes have been implicated in the pathogenesis of genetic heart diseases, including the main inherited cardiomyopathies, such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathies. Understanding how these gene mutations lead to clinical disease and the various secondary genetic and environmental factors, which may modify the clinical phenotype, are key areas of research ultimately influencing diagnosis and management of patients. The emergence of patient-derived induced pluripotent stem cells (iPSCs), which can be differentiated into functional cardiomyocytes (CMs) in vitro, may provide an exciting new approach to understand disease mechanisms underpinning inherited heart diseases. This review will focus specifically on the key role of iPSC-based studies in the inherited cardiomyopathies, both in their potential utility as well as the significant challenges they present.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available